P509 Upadacitinib Improves Symptomatic Responses in Patients with Moderately to Severely Active Crohn’s DiseaseI. Blumenstein,J. Torres,C. Ma,J. O. Lindsay,R. Ungaro,L. Thin,A. P. Lacerda, S. I. Anyanwu,A. Garrison,S. Ford,E. LouisJOURNAL OF CROHNS & COLITIS（2024）引用 0|浏览2AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
